Pnc Financial Services Group, Inc. Veracyte, Inc. Transaction History

Pnc Financial Services Group, Inc.

$190 Billion
Q1 2025

A detailed history of Pnc Financial Services Group, Inc. transactions in Veracyte, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 21,867 shares of VCYT stock, worth $584,286. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,867

Previous 25,439 14.04%

Holding current value

$584,286

Previous $1.01 Million 35.65%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$29.65 - $46.14 $105,909 - $164,812	-3,572 Reduced 14.04%	21,867 $648,000
Q4 2024 Feb 07, 2025	BUY	$31.92 - $44.4 $67,510 - $93,906	2,115 Added 9.07%	25,439 $1.01 Million
Q3 2024 Nov 08, 2024	BUY	$21.0 - $35.25 $29,379 - $49,314	1,399 Added 6.38%	23,324 $793,000
Q2 2024 Aug 09, 2024	BUY	$18.86 - $23.55 $170,984 - $213,504	9,066 Added 70.5%	21,925 $475,000
Q1 2024 May 10, 2024	BUY	$21.0 - $29.1 $116,256 - $161,097	5,536 Added 75.6%	12,859 $284,000
Q4 2023 Feb 09, 2024	BUY	$19.72 - $28.68 $30,980 - $45,056	1,571 Added 27.31%	7,323 $201,000
Q3 2023 Nov 13, 2023	SELL	$22.33 - $29.92 $18,198 - $24,384	-815 Reduced 12.41%	5,752 $128,000
Q2 2023 Aug 11, 2023	BUY	$20.96 - $26.99 $11,402 - $14,682	544 Added 9.03%	6,567 $167,000
Q1 2023 May 15, 2023	SELL	$20.58 - $27.89 $5,145 - $6,972	-250 Reduced 3.99%	6,023 $134,000
Q4 2022 Feb 10, 2023	BUY	$15.31 - $29.94 $4,210 - $8,233	275 Added 4.58%	6,273 $148,000
Q3 2022 Nov 10, 2022	BUY	$16.58 - $27.9 $248 - $418	15 Added 0.25%	5,998 $99,000
Q2 2022 Aug 12, 2022	BUY	$15.45 - $29.52 $370 - $708	24 Added 0.4%	5,983 $119,000
Q1 2022 May 12, 2022	BUY	$21.94 - $42.51 $42,848 - $83,022	1,953 Added 48.75%	5,959 $164,000
Q4 2021 Feb 11, 2022	SELL	$36.09 - $53.79 $11,981 - $17,858	-332 Reduced 7.65%	4,006 $165,000
Q3 2021 Nov 05, 2021	BUY	$35.62 - $52.97 $15,138 - $22,512	425 Added 10.86%	4,338 $201,000
Q2 2021 Aug 06, 2021	SELL	$32.94 - $56.62 $6,983 - $12,003	-212 Reduced 5.14%	3,913 $156,000
Q1 2021 May 07, 2021	BUY	$44.47 - $81.38 $4,624 - $8,463	104 Added 2.59%	4,125 $221,000
Q4 2020 Feb 12, 2021	SELL	$32.49 - $61.88 $72,647 - $138,363	-2,236 Reduced 35.74%	4,021 $196,000
Q3 2020 Nov 06, 2020	SELL	$26.73 - $35.67 $9,622 - $12,841	-360 Reduced 5.44%	6,257 $203,000
Q2 2020 Aug 07, 2020	BUY	$19.49 - $28.11 $13,740 - $19,817	705 Added 11.92%	6,617 $171,000
Q1 2020 May 08, 2020	BUY	$16.13 - $30.17 $19,710 - $36,867	1,222 Added 26.06%	5,912 $143,000
Q4 2019 Feb 07, 2020	BUY	$20.78 - $29.99 $89,146 - $128,657	4,290 Added 1072.5%	4,690 $130,000
Q3 2019 Nov 08, 2019	BUY	$23.87 - $30.93 $9,548 - $12,372	400 New	400 $9,000

Others Institutions Holding VCYT

# of Institutions

306

Shares Held

79.1M

Call Options Held

15.5K

Put Options Held

16.7K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $1.91B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account

Pnc Financial Services Group, Inc. Veracyte, Inc. Transaction History